OnTrackCF: Engagement, Feasibility, and Acceptability Study
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This is a multi-site, nonrandomized study using mixed methods approach to evaluate the feasibility, acceptability, and user engagement of OnTrackCF for adults with Cystic Fibrosis (AWCF).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Diagnosed with CF
• 18+ years of age
• Prescribed a CFTR modulator therapy to be taken twice a day
• Can speak and read English
• Have regular access to an iOS or Android tablet or smartphone with internet access.
Locations
United States
Alabama
University of Alabama-Birmingham
NOT_YET_RECRUITING
Birmingham
Massachusetts
Boston Children's Hospital
RECRUITING
Boston
Maryland
Johns Hopkins University
NOT_YET_RECRUITING
Baltimore
Contact Information
Primary
Emma M McWilliams, BA
emma.mcwilliams@childrens.harvard.edu
617-355-7534
Backup
Callie Bacon, MPH
callie.bacon@childrens.harvard.edu
617-919-7696
Time Frame
Start Date: 2025-11-20
Estimated Completion Date: 2026-12
Participants
Target number of participants: 60
Treatments
Experimental: Participation
Participants eligible to enroll will be provided with the OnTrackCF app (intervention), and will use the app for 4-12 weeks before completing feasibility measures and a qualitative interview.
Related Therapeutic Areas
Sponsors
Collaborators: Cystic Fibrosis Foundation, Johns Hopkins University, University of Alabama at Birmingham
Leads: Boston Children's Hospital